ArticleDiabetes & metabolic syndrome

Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.).

Timur Ekiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.